DaVita Total Non-Operating Income/Expense 2010-2024 | DVA

DaVita annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • DaVita total non-operating income/expense for the quarter ending September 30, 2024 was $-0.161B, a 37.13% increase year-over-year.
  • DaVita total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.509B, a 17.46% increase year-over-year.
  • DaVita annual total non-operating income/expense for 2023 was $-0.426B, a 14.19% increase from 2022.
  • DaVita annual total non-operating income/expense for 2022 was $-0.373B, a 33.67% increase from 2021.
  • DaVita annual total non-operating income/expense for 2021 was $-0.279B, a 25.9% decline from 2020.
DaVita Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-426
2022 $-373
2021 $-279
2020 $-376
2019 $-448
2018 $-477
2017 $-413
2016 $-407
2015 $-448
2014 $-505
2013 $-425
2012 $-296
2011 $-238
2010 $-253
2009 $-182
DaVita Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-161
2024-06-30 $-135
2024-03-31 $-112
2023-12-31 $-101
2023-09-30 $-118
2023-06-30 $-110
2023-03-31 $-97
2022-12-31 $-109
2022-09-30 $-105
2022-06-30 $-84
2022-03-31 $-76
2021-12-31 $-74
2021-09-30 $-80
2021-06-30 $-58
2021-03-31 $-66
2020-12-31 $-54
2020-09-30 $-154
2020-06-30 $-72
2020-03-31 $-96
2019-12-31 $-81
2019-09-30 $-105
2019-06-30 $-138
2019-03-31 $-125
2018-12-31 $-129
2018-09-30 $-122
2018-06-30 $-118
2018-03-31 $-109
2017-12-31 $-104
2017-09-30 $-106
2017-06-30 $-103
2017-03-31 $-100
2016-12-31 $-104
2016-09-30 $-103
2016-06-30 $-100
2016-03-31 $-100
2015-12-31 $-99
2015-09-30 $-101
2015-06-30 $-150
2015-03-31 $-98
2014-12-31 $-98
2014-09-30 $-101
2014-06-30 $-202
2014-03-31 $-105
2013-12-31 $-104
2013-09-30 $-106
2013-06-30 $-109
2013-03-31 $-105
2012-12-31 $-106
2012-09-30 $-70
2012-06-30 $-60
2012-03-31 $-60
2011-12-31 $-61
2011-09-30 $-60
2011-06-30 $-59
2011-03-31 $-58
2010-12-31 $-123
2010-09-30 $-39
2010-06-30 $-47
2010-03-31 $-44
2009-12-31 $-44
2009-09-30 $-45
2009-06-30 $-46
2009-03-31 $-48
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.098B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00